Divis Laboratories Beat Estimates
Tuesday, June 10, 2008
Divis Labs Ltd (DLL) reported revenues of Rs2.8 bn. EBITDA margins at 41% were significantly higher and PAT was Rs 927 mn.CRAMS and generics comprise around 50% of business. There were no one-time large orders registered this quarter. Thus, revenue line is likely to be maintained for the next few quarters.
Divis nutraceuticals plant which was commissioned in June 2008 and FY2009 will see the first year of revenues from this business.Sales is expected to grow by 48% and 40% in FY09 and FY10. Fully diluted EPS could be in the range of Rs 76 to Rs 80 for FY09.
Recent Corporate Earnings / Breaking News
- Suzlon Energy out of current
- Voltamp Transformer - Electrifying Results
- Canara Bank - New Businesses for Future Growth
- PVR Cinemas - Super Hit FY 2008
- Emco Ltd - Steady Current
- Transport Corporation of India
- IT spend strong amidst declining profits in US
- Inflation to Rise Post Hikes
- TRF Ltd - Temporary Blip of Slowdown ?
- VIP Industries - Dismal Performance
